April, 2023
Read More
The anatomy Pathology market size is valued at USD 20.2 Billion in 2022. Further, over the forecast period from 2023 to 2030, anatomic pathology instruments, consumables and accessories are poised to register a 6.73% CAGR. Breast cancer, Cervical Cancer, Prostate Cancer, Colorectal Cancer, Lung Cancer, and other Diagnostics are among the key applications of anatomic pathology products. The report analyzes the market growth potential across clinical diagnostic laboratories, hospitals, and other settings.
Anatomy Pathology - Market Report Highlights, 2023
Anatomic Pathology Market Size Outlook, 2021 to 2030
Anatomic Pathology Market Analysis, 2023
Growing awareness about various health disorders, the increasing prevalence of chronic conditions, the aging population, and changing lifestyles are encouraging companies to develop testing and diagnostic solutions across the industry. Companies like Abbott, Roche, and others are focusing on constantly widening their product portfolio across wide conditions that impact patients.
Diagnostic services play a vital role in spotting health problems and providing information on required medical interventions well in advance. Aging populations and changing lifestyles are among the main factors promoting health-related disorders and increasing awareness of these conditions are main market drivers. As early diagnosis boosts the possibility of positive outcomes and can lower further treatment costs, an increasing drive toward diagnostics is being observed. Significant improvements in healthcare infrastructure across developing countries like China, India, Brazil, and others coupled with growth in advanced diagnostic techniques offer significant market potential.
Anatomic pathology is a branch of pathology that encompasses the diagnosis of lung cancer, breast cancer, colorectal cancer, and chronic conditions such as kidney diseases, liver disease, autoimmune diseases, and infectious diseases through the examination of tissue and cell samples collected through biopsy.
The global anatomic pathology market is estimated to be valued at $20.2 billion in 2022. The market witnessed a swift recovery of 6.35% during 2022 over 2021. Over the forecast period, the market is poised to register robust growth at a 6.73% compounded annual growth rate (CAGR) between 2023 and 2030 to reach $33.9 billion by end of the forecast period.
Driven by the increasing prevalence of cancer and chronic conditions, awareness towards early detection of cancer, physicians increasingly recommending cancer screening, emphasis on personalized medicines, and widespread availability of reimbursement for anatomic pathology diagnosis and treatment are the main factors fuelling the global market growth.
In-situ hybridization (ISH) techniques such as fluorescence in-situ hybridization (FISH), immunohistochemistry (IHC), and digital pathology methods are widely used in the industry. Globally, the demand for early cancer screening is driving anatomic pathology, which assists physicians to identify abnormality at the molecular level. In addition, the pathology also assists in the identification of the expression of cellular proteins and genes.
On the other hand, the availability of refurbished products, the dearth of skilled professionals, in particular, in developing countries, and product recalls will act as major restraints to the global market growth over the forecast period.
Market Trends- Anatomic Pathology Consumables and Accessories Dominate the Global Markets
Based on types, the global anatomic pathology market is categorized into Instruments and imaging systems Consumables, and accessories. During 2023, consumables and accessories are expected to account for the largest share of 78.8%. The demand for consumables and accessories is increasing in the market owing to their increasing use. The requirement of antibodies, kits and reagents, probes, and other consumables in cancer screening is another driver for this segment.
The report also analyses the global and regional markets into applications including Breast cancer, Lung cancer, colorectal cancer, Lymphoma, Cervical cancer, Prostate cancer, and other diseases. Of these, lung cancer dominates the global anatomic pathology market, due to the high prevalence of the condition amidst smoking habits, recurring inflammation of the lung, exposure to carcinogens and asbestos, family history, and other factors.
Anatomic Pathology- Geographic Analysis
The report categorizes the global anatomic pathology into regions including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. During 2022, North America dominated the global market with the US leading the regional markets. Increasing cancer and chronic disease prevalence, a well-established healthcare industry, high-quality infrastructure for hospitals and clinical laboratories, and the presence of capital-intensive, technically sound companies present potential for growth. Asia Pacific, on the other hand, is rapidly emerging as the potential target market driven by a large population base, the prevalence of chronic diseases, improving the standard of living, increasing healthcare expenditure, and strengthening reimbursement policies are the main market drivers. Further, developing countries such as China, India, and Brazil will offer strong growth opportunities for companies operating in the market over the medium to long term future.
Key players operating in the industry include F. Hoffmann-La Roche Ltd, Danaher Corporation, Agilent Technologies, Becton, Dickinson and Company, PHC Holdings Corporation, Sakura Finetek, Merck KGaA, Bio SB, Diapath SpA, BioGenex Laboratories.
Among developing countries, initiatives by NGOs and governments to create awareness of precautionary measures, testing options, and their advantages are encouraging market growth. Increasing diseases and infections require specific healthcare facilities and accordingly, investments from both public and private sectors continue to increase in the sector. Further, an increasing trend towards the development of medium to large-scale diagnostic and imaging centers in public-private-partnership (PPP) models are being observed.
Anatomic Pathology Market Trends- Significant interest of private equity investors in the market
Inorganic growth expansion through acquisitions is the main strategy of leading companies such as Laboratory Corporation of America Holdings (LabCorp) and Quest Diagnostics focus on expanding through.
Further, companies including Linden Capital Partners, Audax Private Equity, Pritzker Group Private Capital, Vesey Street Capital Partners, Arch Overage Fund, Donaldson, Artiman, Longwall Venture Partners, Esperante, Lufkin, Jenrette, the Wall Street brokerage house. 21st Century Health Ventures, Cormorant Asset Management, Trinitas Capital, Consonance Capital Partners, TPG Growth, BelHealth Investment Partners, Google Ventures, Foundation Medical Partners, North Bridge Venture Partners, General Catalyst Partners, Levine Leichtman Capital Partners, among others are also increasingly investing in diagnostics services.
Capital supply from venture capitalists will accelerate the development of the anatomic pathology testing market. These private equities and venture capitalists invest through private equity funds, hedge funds, royalty funds, and other investments, which will support business expansion and R&D activities in the industry.
Anatomic Pathology Market Companies profiled in the Report-
Anatomic Pathology Market Segmentation-
Types
Applications
End User Verticals
Regions
1. Executive Summary
1.1 Introduction to Anatomic Pathology Markets
1.2 Anatomic Pathology Market Size Outlook, 2021- 2030
1.3 Growth Opportunities in Anatomic Pathology Industry
1.4 Winning Strategies for the post-pandemic future
2. Report Guide
2.1 Market Definition and Scope
2.2 Market Segmentation
2.3 Research Methodology
2.4 Forecast Methodology
2.5 List of Abbreviations
3. Growth Opportunity Analysis
3.1 Key Anatomic Pathology Market Trends
3.1.1 Significant interest of private equity investors in the market
3.1.2 Ready to Use Reagents and long term agreements for reagents witness strong demand
3.1.3 Refurbished diagnostic systems present significant market potential
3.1.4 Private diagnostic and imaging centers hold the key to future
3.2 Key Anatomic Pathology Market Growth Drivers
3.2.1 Increasing global Healthcare Expenditure worldwide is among the main market drivers
3.2.6 High incidence of cancer across the world drives market outlook
3.2.7 Initiatives by governments for early cancer diagnosis
3.2.8 Huge market potential from emerging economies
3.3 Key Anatomic Pathology Market Growth Restraints
3.3.1 Lack of trained personnel pose market expansion challenges
3.3.2 High cost of diagnostic imaging systems and procedures restrict wider penetration
3.3.3 Product failures and recalls
4 Anatomic Pathology Market Outlook – Scenario Analysis
4.1 Low Growth Case Scenario Forecasts: Anatomic Pathology Market Size Outlook to 2030
4.2 Reference Growth Case Scenario Forecasts: Anatomic Pathology Market Size Outlook to 2030
4.3 High Growth Case Scenario Forecasts: Anatomic Pathology Market Size Outlook to 2030
5. Anatomic Pathology Market Segmentation- Outlook by Type
5.1 Anatomic Pathology Market Share Analysis by Type, 2023
5.2 Anatomic Pathology Instruments Market Outlook to 2030
5.3 Anatomic Pathology Consumables and Accessories Market Outlook to 2030
6. Anatomic Pathology Market Segmentation- Outlook by Application
6.1 Anatomic Pathology Market Share Analysis by Application, 2023
6.2 Breast Cancer: Anatomic Pathology Market Revenue Outlook to 2030
6.3 Cervical Cancer: Anatomic Pathology Market Revenue Outlook to 2030
6.4 Prostate Cancer: Anatomic Pathology Market Revenue Outlook to 2030
6.5 Colorectal Cancer: Anatomic Pathology Market Revenue Outlook to 2030
6.6 Lung Cancer: Anatomic Pathology Market Revenue Outlook to 2030
6.7 Other Indications: Anatomic Pathology Market Revenue Outlook to 2030
7. Anatomic Pathology Market Segmentation- Outlook by End-Use Industry
7.1 Anatomic Pathology Market Share Analysis by End-Use Industry, 2023
7.2 Clinical Diagnostic Laboratories: Anatomic Pathology Market Revenue Outlook to 2030
7.3 Hospitals: Anatomic Pathology Market Revenue Outlook to 2030
7.4 Others: Anatomic Pathology Market Revenue Outlook to 2030
8. North America Anatomic Pathology Market Outlook and Opportunities to 2030
8.1 Market Snapshot, 2023
8.2 North America Anatomic Pathology Market Growth Opportunities
8.2.1 North America Anatomic Pathology Market Outlook by Type, 2021 to 2030
8.2.2 North America Anatomic Pathology Market Outlook by Disease, 2021 to 2030
8.2.3 North America Anatomic Pathology Market Outlook by End-User Industry, 2021 to 2030
8.2.4 North America Anatomic Pathology Market Outlook by Country, 2021 to 2030
8.3 United States Anatomic Pathology Market Outlook, 2021 to 2030
8.4 Canada Anatomic Pathology Market Outlook, 2021 to 2030
8.5 Mexico Anatomic Pathology Market Outlook, 2021 to 2030
9. Europe Anatomic Pathology Market Outlook and Opportunities to 2030
9.1 Market Snapshot, 2023
9.2 Europe Anatomic Pathology Market Growth Opportunities
9.2.1 Europe Anatomic Pathology Market Outlook by Type, 2021 to 2030
9.2.2 Europe Anatomic Pathology Market Outlook by Disease, 2021 to 2030
9.2.3 Europe Anatomic Pathology Market Outlook by End-User Industry, 2021 to 2030
9.2.4 Europe Anatomic Pathology Market Outlook by Country, 2021 to 2030
9.3 Germany Anatomic Pathology Market Outlook, 2021 to 2030
9.4 France Anatomic Pathology Market Outlook, 2021 to 2030
9.5 United Kingdom Anatomic Pathology Market Outlook, 2021 to 2030
9.6 Spain Anatomic Pathology Market Outlook, 2021 to 2030
9.7 Italy Anatomic Pathology Market Outlook, 2021 to 2030
9.8 Other Europe Anatomic Pathology Market Outlook, 2021 to 2030
10. Asia Pacific Anatomic Pathology Market Outlook and Opportunities to 2030
10.1 Market Snapshot, 2023
10.2 Asia Pacific Anatomic Pathology Market Growth Opportunities
10.2.1 Asia Pacific Anatomic Pathology Market Outlook by Type, 2021 to 2030
10.2.2 Asia Pacific Anatomic Pathology Market Outlook by Disease, 2021 to 2030
10.2.3 Asia Pacific Anatomic Pathology Market Outlook by End-User Industry, 2021 to 2030
10.2.4 Asia Pacific Anatomic Pathology Market Outlook by Country, 2021 to 2030
10.3 China Anatomic Pathology Market Outlook, 2021 to 2030
10.4 Japan Anatomic Pathology Market Outlook, 2021 to 2030
10.5 India Anatomic Pathology Market Outlook, 2021 to 2030
10.6 South Korea Anatomic Pathology Market Outlook, 2021 to 2030
10.7 Indonesia Anatomic Pathology Market Outlook, 2021 to 2030
10.8 Other Asia Pacific Anatomic Pathology Market Outlook, 2021 to 2030
11. South and Central America Anatomic Pathology Market Outlook and Opportunities to 2030
11.1 Market Snapshot, 2023
11.2 South and Central America Anatomic Pathology Market Growth Opportunities
11.2.1 South and Central America Anatomic Pathology Market Outlook by Type, 2021 to 2030
11.2.2 South and Central America Anatomic Pathology Market Outlook by Disease, 2021 to 2030
11.2.3 South and Central America Anatomic Pathology Market Outlook by End-User Industry, 2021 to 2030
11.2.4 South and Central America Anatomic Pathology Market Outlook by Country, 2021 to 2030
11.3 Brazil Anatomic Pathology Market Outlook, 2021 to 2030
11.4 Argentina Anatomic Pathology Market Outlook, 2021 to 2030
11.5 Other Latin America Anatomic Pathology Market Outlook, 2021 to 2030
12. Middle East and Africa Anatomic Pathology Market Outlook and Opportunities to 2030
12.1 Market Snapshot, 2023
12.2 Middle East and Africa Anatomic Pathology Market Growth Opportunities
12.2.1 Middle East and Africa Anatomic Pathology Market Outlook by Type, 2021 to 2030
12.2.2 Middle East and Africa Anatomic Pathology Market Outlook by Disease, 2021 to 2030
12.2.3 Middle East and Africa Anatomic Pathology Market Outlook by End-User Industry, 2021 to 2030
12.2.4 Middle East and Africa Anatomic Pathology Market Outlook by Country, 2021 to 2030
12.3 Saudi Arabia Anatomic Pathology Market Outlook, 2021 to 2030
12.4 United Arab Emirates (the UAE) Anatomic Pathology Market Outlook, 2021 to 2030
12.5 Other Middle East Anatomic Pathology Market Outlook, 2021 to 2030
12.6 Egypt Anatomic Pathology Market Outlook, 2021 to 2030
12.7 South Africa Anatomic Pathology Market Outlook, 2021 to 2030
12.8 Other Africa Anatomic Pathology Market Outlook, 2021 to 2030
13. Profiles of major world Anatomic Pathology Companies
13.1 F. Hoffmann-La Roche Ltd
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
13.2 Danaher Corporation
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
13.3 PHC Holdings Corp
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
13.4 Agilent Technologies
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
13.5 Becton, Dickinson, and Company
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
13.6 Merck KGaA
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
13.7 Hologic Inc
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
13.8 BioGenex
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
13.9 Diapath SpA
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
13.10 Bio SB
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
14. Appendix
14.1 Publisher’s Expertise
14.2 List of Tables and Charts
14.3 List of Exhibits
14.4 Legal Disclaimer
Significant interest of private equity investors, Ready-to-Use Reagents and long term agreements for reagents, Refurbished diagnostic systems present significant market potential, Private diagnostic and imaging centers hold the key for future, High incidence of cancer across the world, Initiatives by governments for early cancer diagnosis, Huge market potential from emerging economies and increasing global Healthcare Expenditure worldwide are among the main market drivers
The global anatomic pathology market generated a revenue of $20.2 billion in 2022, witnessing a swift recovery over previous year.
The Anatomic pathology market is poised to register robust growth at a 6.73% CAGR between 2023 and 2030 to reach $33.9 billion by end of the forecast period
F. Hoffmann-La Roche Ltd, Danaher Corporation, Agilent Technologies, Becton, Dickinson and Company, PHC Holdings Corporation, Sakura Finetek, Merck KGaA, Bio SB, Diapath SpA, BioGenex Laboratories.
The report presents insights into Breast cancer, Lung cancer, colorectal cancer, Lymphoma, Cervical cancer, Prostate cancer, and other diseases. Of these, lung cancer dominates the global anatomic pathology market with 20.4% market share